Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Research To Practice | Oncology Videos · Dr. Neil Love
November 29, 202558m 54s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Dr Komal Jhaveri and Dr Virginia Kaklamani, including the following topics:
- Introduction: Oral Selective Estrogen Receptor Degraders (SERDs) for the General Medical Oncologist (0:00)
- SERD Monotherapy (13:34)
- SERD and CDK Inhibitor Combination — The EMBER-3 Study (35:58)
- SERDs for "Molecular Progression" — The SERENA-6 Study (41:25)